Verrica Pharmaceuticals (VRCA) announced the presentation of three posters that were presented at the 2025 Winter Clinical Dermatology ...

To motivate students and prolong the long-term impact, my department, which hosted an international applied linguistics conference during the semester, offered students the opportunity to be invited ...

LOS ANGELES, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company ...

Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease ...

In accordance with ASX Listing Rule 4.7C, payments of A$126K made to related parties and their associates included in item 6.1 of the Appendix 4C incorporates directors’ fees, consulting fees, ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel, first-in-class biologic therapy ...

A research exhibition titled 'Poster Presentations' was organized late Tuesday at the Central Library of Allama Iqbal Open University ...

An event hosted by the university saw speakers accuse Jewish groups of being complicit in the spread of ‘racism, Islamophobia ...

Abstract Title: "BXQ-350, a novel sphingolipid metabolism modulator, in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal cancer (mCRC) patients: A phase 1b/2 ...

Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction ...